Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

The Physiological and Clinical Effects of Interrupting a Treatment Regimen of Hydroxyurea in Young Children with Sickle Cell Anemia (SCA)

Bruce W Thompson, PhD, Winfred C Wang, MD, Scott T. Miller, MD, Zora R. Rogers, MD, Russell E. Ware, MD, PhD, Courtney D. Thornburg, MD, MS, Sohail R. Rana, MD, Lori Luchtman-Jones, MD, Rathi V. Iyer, MD, James F. Casella, MD

Blood (2011) 118 (21): 2134.

https://doi.org/10.1182/blood.V118.21.2134.2134

Published: 2011

Journal Articles

Hydroxyurea Treatment of Young Children with Sickle Cell Anemia: Safety and Efficacy of Continued Treatment – the BABY HUG Follow-up Study

Zora R. Rogers, MD, Billie Fish, CCRP, Zhaoyu Luo, PhD, Rathi V. Iyer, MD, Courtney D. Thornburg, MD, MS, Sharada A. Sarnaik, MD, Sohail R. Rana, MD, Lori Luchtman-Jones, MD, Sherron M. Jackson, MD, Thomas H. Howard, MD, James F. Casella, MD, R. Clark Brown, MD, PhD, Ofelia A. Alvarez, MD, Jonathan C. Goldsmith, MD, Scott T. Miller, MD, Winfred C. Wang, MD

Blood (2011) 118 (21): 7.

https://doi.org/10.1182/blood.V118.21.7.7

Published: 2011

Journal Articles

Refining Th Predictive Value of Secretory Phospholipase A2 In Sickle Cell Disease Patients with Acute Chest Syndrome

Lori Styles, MD, Carrie Greene Wager, PhD, Richard J. Labotka, MD, MS, Kim Smith-Whitley, MD, Alexis A. Thompson, MD, MPH, Peter A. Lane, JR, MD, Lillian McMahon, MD, Robin Miller, MD, Susan D. Roseff, MD, Dianne Gallagher, Rathi V. Iyer, MD, Scott Miller, MD

Blood (2010) 116 (21): 846.

https://doi.org/10.1182/blood.V116.21.846.846

Published: 2010

Journal Articles

Influence of Hemoglobin Level on Clinical Findings In Infants with Sickle Cell Anemia: Data From BABY HUG

Jeffrey D. Lebensburger, DO, Scott T Miller, MD, Thomas H. Howard, MD, James F. Casella, MD, R. Clark Brown, MD, PhD, Ming Lu, MS, Rathi V. Iyer, MD, Zora R. Rogers, MD, Winfred C. Wang, MD

Blood (2010) 116 (21): 1631.

https://doi.org/10.1182/blood.V116.21.1631.1631

Published: 2010

Journal Articles

The Role of Immune-Response Gene Variants in Inhibitor Development in Black Patients with Hemophilia A.

Tom E. Howard, MD, PhD, Shelley A. Cole, PhD, Carol K. Kasper, MD, Afshin Ameri, MD, Kavita Natarajan, MD, Raymond G. Watts, MD, Valrie A. Manard, RN, Shelley M. Nakaya, Christine L Kempton, MD, MSc, Martina Kennedy, DO, Benjamin Kim, MD, Rathi V. Iyer, MD, Laura Almasy, PhD

Blood (2009) 114 (22): 1301.

https://doi.org/10.1182/blood.V114.22.1301.1301

Published: 2009

Journal Articles

Elevated Systolic Blood Pressure and Low Fetal Hemoglobin Are Risk Factors for Silent Cerebral Infarcts in Children with Sickle Cell Anemia.

Blood (2009) 114 (22): 262.

https://doi.org/10.1182/blood.V114.22.262.262

Published: 2009

Journal Articles

Study Drug and Visit Adherence: Data from the BABY HUG Trial.

Courtney D. Thornburg, MD, MS, Zora R. Rogers, MD, Winfred Wang, MD, Michael Jeng, MD, Sohail R Rana, MD, Rathi V. Iyer, MD, Lane Faughnan, RN, BSN, CCRP, Jennifer Marshall, RN, ADN, CLNC, Leann Hassen, MPH, Roy McDonald, MPH, Renee C. Rees, PhD, for The BABY HUG Investigators

Blood (2008) 112 (11): 1275.

https://doi.org/10.1182/blood.V112.11.1275.1275

Published: 2008

Journal Articles

Urine Concentrating Ability in Infants with Sickle Cell Anemia: Baseline Data from the BABY HUG Trial.

Scott T. Miller, MD, Winfred C. Wang, MD, Rathi V. Iyer, MD, Sohail R Rana, MD, Peter A. Lane, Jr., MD, Russell E. Ware, MD, PhD, Renee C Rees, PhD, The BABY HUG Investigators

Blood (2008) 112 (11): 1413.

https://doi.org/10.1182/blood.V112.11.1413.1413

Published: 2008

Journal Articles

Renal Function in Infants with Sickle Cell Anemia: Baseline Data from the BABY HUG Trial.

Russell E. Ware, MD, PhD, Renee C. Rees, PhD, Sharada A. Sarnaik, MD, Rathi V. Iyer, MD, Ofelia A. Alvarez, MD, James F. Casella, MD, Barry L. Shulkin, MD, Eglal Shalaby-Rana, MD, C. Frederic Strife, MD, John H. Miller, MD, Peter A. Lane, Jr., MD, Winfred C. Wang, Scott T. Miller, MD, The BABY HUG Investigators

Blood (2008) 112 (11): 1414.

https://doi.org/10.1182/blood.V112.11.1414.1414

Published: 2008

Journal Articles

Serum Cystatin-C Levels in Infants with Sickle Cell Anemia: Baseline Data from the BABY HUG Trial

Scott T. Miller, MD, Russell E. Ware, MD, PhD, Abdullah Kutlar, MD, Ofelia A. Alvarez, MD, Rathi V. Iyer, MD, Sharada A. Sarnaik, MD, Sohail R Rana, MD, Zora R. Rogers, MD, Peter A. Lane, Jr., MD, Renee C Rees, PhD, The BABY HUG Investigators

Blood (2008) 112 (11): 4791.

https://doi.org/10.1182/blood.V112.11.4791.4791

Published: 2008

Journal Articles

Transcranial Doppler (TCD) Ultrasonography in Infants with Sickle Cell Anemia: Baseline Data from the BABY HUG Trial.

Winfred Wang, MD, Renee C Rees, PhD, Scott T. Miller, MD, R. Clark Brown, MD, PhD, James F. Casella, MD, Rathi V. Iyer, MD, Ram V. Kalpathi, M.D., Judy Luden, Zora R. Rogers, MD, Courtney Thornberg, M.D., Robert J. Adams, MD, Steven Pavlakis, MD, the BABY HUG Investigators

Blood (2008) 112 (11): 1436.

https://doi.org/10.1182/blood.V112.11.1436.1436

Published: 2008

Journal Articles

Spleen Function in Infants with Sickle Cell Anemia: Baseline Data from the BABY HUG Trial.

Zora R. Rogers, MD, Renee C. Rees, PhD, Beatrice Files, MD, Rathi V. Iyer, MD, Barry L. Shulkin, MD, Eglal Shalaby-Rana, MD, John H. Miller, MD, Stephen D. Dertinger, PhD, Peter A. Lane, MD, Winfred C. Wang, MD, Russell E. Ware, MD, PhD, The BABY HUG Investigators

Blood (2008) 112 (11): 1416.

https://doi.org/10.1182/blood.V112.11.1416.1416

Published: 2008

Journal Articles

Serum Ferritin in Children with Sickle Cell Disease on Chronic Transfusion: Measure of Iron Overload or End Organ Injury? STOP/STOP II Liver Iron Ancillary Study.

Tom Adamkiewicz, MD, Miguel R. Abboud, MD, Julio C. Barredo, MD, Melanie Kirby-Allen, MD, Ofelia A. Alvarez, MD, James F. Casella, MD, Rathi V. Iyer, MD, Virgil McKie, MD, Gerald Milton Woods, MD, Abdullah Kutlar, MD, Carole Paley, MD, Jessica Peterson, Elizabeth Rackoff, Manuela Merelles-Pulcini, Elizabeth Dackiw, Kristin Stegenga, Nadine Odo, Mimi Lou, Robert J. Adams, MD

Blood (2006) 108 (11): 791.

https://doi.org/10.1182/blood.V108.11.791.791

Published: 2006

Journal Articles

Allelically Mismatched Replacement Therapy Due to Common African−Restricted Haplotypes of the Factor (F)VIII Protein May Underlie the Increased Incidence of FVIII Inhibitors Observed in Hemophilia−A Patients of African−Descent.

Tom E. Howard, MD, PhD, Kevin R. Viel, BS, Karl M. Fernstrom, BS, Seema Deshpande, PhD, Afshin Ameri, MD, M. Showkat Ali, PhD, Cynthia Channell, BS, Rathi V. Iyer, MD, Raymond G. Watts, MD, Charles Lutcher, MD, Shelley Nakaya, BS, Carol K. Kasper, MD, Arthur R. Thompson, MD, PhD, Thomas C. Abshire, MD, Laura Almasy, PhD

Blood (2006) 108 (11): 765.

https://doi.org/10.1182/blood.V108.11.765.765

Published: 2006

Journal Articles

The Pharmacogenetics and Inhibitor Risk (PIR) Study: Establishing the Spectrum of Factor (F)VIII Gene (F8) Mutations in African-American Hemophilia A Patients.

Tom E. Howard, MD, PhD, Deepa K. Machiah, BS, Kevin R. Viel, PhD, Cynthia Channel, BS, Afshin Ameri, MD, Rathi V. Iyer, MD, Ray G. Watts, MD, Charles Lutcher, MD, Joanna Davis, MD, Thomas C. Abshire, MD, Laura Almasy, PhD

Blood (2005) 106 (11): 3207.

https://doi.org/10.1182/blood.V106.11.3207.3207

Published: 2005

Journal Articles

Pharmacokinetics of Hydroxyurea in Young Children with Sickle Cell Anemia: A Report from the BABY HUG Trial.

Zora R. Rogers, MD, Bruce Thompson, PhD, Russell E. Ware, MD, PhD, Winfred C. Wang, MD, Rathi V. Iyer, MD, Scott T. Miller, MD, Caterina Minniti, MD, Sohail Rana, MD, Julio C. Barredo, MD, Stuart Toledano, MD, Sherri A. Zimmerman, MD, James F. Casella, MD, Beatrice A. Files, MD, Myron A. Waclawiw, PhD, A. Russell Gerber, MD, Duane R. Bonds, MD

Blood (2005) 106 (11): 3184.

https://doi.org/10.1182/blood.V106.11.3184.3184

Published: 2005

NARROW

The Physiological and Clinical Effects of Interrupting a Treatment Regimen of Hydroxyurea in Young Children with Sickle Cell Anemia (SCA)

Hydroxyurea Treatment of Young Children with Sickle Cell Anemia: Safety and Efficacy of Continued Treatment – the BABY HUG Follow-up Study

Refining Th Predictive Value of Secretory Phospholipase A2 In Sickle Cell Disease Patients with Acute Chest Syndrome

Influence of Hemoglobin Level on Clinical Findings In Infants with Sickle Cell Anemia: Data From BABY HUG

The Role of Immune-Response Gene Variants in Inhibitor Development in Black Patients with Hemophilia A.

Elevated Systolic Blood Pressure and Low Fetal Hemoglobin Are Risk Factors for Silent Cerebral Infarcts in Children with Sickle Cell Anemia.

Study Drug and Visit Adherence: Data from the BABY HUG Trial.

Urine Concentrating Ability in Infants with Sickle Cell Anemia: Baseline Data from the BABY HUG Trial.

Renal Function in Infants with Sickle Cell Anemia: Baseline Data from the BABY HUG Trial.

Serum Cystatin-C Levels in Infants with Sickle Cell Anemia: Baseline Data from the BABY HUG Trial

Transcranial Doppler (TCD) Ultrasonography in Infants with Sickle Cell Anemia: Baseline Data from the BABY HUG Trial.

Spleen Function in Infants with Sickle Cell Anemia: Baseline Data from the BABY HUG Trial.

Serum Ferritin in Children with Sickle Cell Disease on Chronic Transfusion: Measure of Iron Overload or End Organ Injury? STOP/STOP II Liver Iron Ancillary Study.

Allelically Mismatched Replacement Therapy Due to Common African−Restricted Haplotypes of the Factor (F)VIII Protein May Underlie the Increased Incidence of FVIII Inhibitors Observed in Hemophilia−A Patients of African−Descent.

The Pharmacogenetics and Inhibitor Risk (PIR) Study: Establishing the Spectrum of Factor (F)VIII Gene (F8) Mutations in African-American Hemophilia A Patients.

Pharmacokinetics of Hydroxyurea in Young Children with Sickle Cell Anemia: A Report from the BABY HUG Trial.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only